Drug–Drug Interactions and Pharmacogenomic Evaluation in Colorectal Cancer Patients: The New Drug-PIN<sup>®</sup> System Comprehensive Approach
Drug–drug interactions (DDIs) can affect both treatment efficacy and toxicity. We used Drug-PIN<sup>®</sup> (Personalized Interactions Network) software in colorectal cancer (CRC) patients to evaluate drug–drug–gene interactions (DDGIs), defined as the combination of DDIs and individual...
Main Authors: | Michela Roberto, Alessandro Rossi, Martina Panebianco, Leda Marina Pomes, Giulia Arrivi, Debora Ierinò, Maurizio Simmaco, Paolo Marchetti, Federica Mazzuca |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/1/67 |
Similar Items
-
Pharmacogenomics in drug discovery and development /
by: Yan, Qing, 1971-
Published: (2008) -
Optimising migraine treatment: from drug-drug interactions to personalized medicine
by: Leda Marina Pomes, et al.
Published: (2019-05-01) -
Evaluation of Drug—Drug Interactions in EGFR-Mutated Non-Small-Cell Lung Cancer Patients during Treatment with Tyrosine-Kinase Inhibitors
by: Mario Occhipinti, et al.
Published: (2021-05-01) -
Safety Profile of Medicines Used for the Treatment of Drug-Resistant Tuberculosis: A Descriptive Study Based on the WHO Database (VigiBase<sup>®</sup>)
by: Alemayehu Lelisa Duga, et al.
Published: (2023-04-01) -
Interpolymer Complexes of Eudragit<sup>®</sup> Copolymers as Novel Carriers for Colon-Specific Drug Delivery
by: Aleksandra V. Bukhovets, et al.
Published: (2020-06-01)